Abstract
Phospholipases A2 (PLA2) comprise a set of extracellular and intracellular enzymes that catalyze the hydrolysis of the sn-2 fatty acyl bond of phospholipids to yield fatty acids and lysophospholipids. The PLA2 reaction is the primary pathway through which arachidonic acid (AA) is released from phospholipids. PLA2s have an important role in cellular death that occurs via necrosis or apoptosis. Reactive oxygen species are known to contribute to tissue damage during injury and inflammation. However, the species can also be sensed by the cells and trigger intracellular signaling cascades during cell death. This review examines recent evidence on the involvement of reactive oxygen species in lipid signaling during apoptosis and necrosis. Attention is focused on activation of PLA2s and lipoxygenases, which play important roles in mediating AA release and metabolism. The participation of several types of PLA2s in AA mobilization from phospholipids is discussed. The involvement of alternative routes for AA mobilization under oxidative stress is also considered.
Keywords: phospholipids, membrane permeability, prostaglandins, LOX expression, Reactive oxygen species
Current Enzyme Inhibition
Title: The Role of Phospholipase A2 and Lipoxygenases Associated with Arachidonic Acid in Oxidative Stress-Induced Cell Injury
Volume: 3 Issue: 4
Author(s): Yoshihiro Higuchi
Affiliation:
Keywords: phospholipids, membrane permeability, prostaglandins, LOX expression, Reactive oxygen species
Abstract: Phospholipases A2 (PLA2) comprise a set of extracellular and intracellular enzymes that catalyze the hydrolysis of the sn-2 fatty acyl bond of phospholipids to yield fatty acids and lysophospholipids. The PLA2 reaction is the primary pathway through which arachidonic acid (AA) is released from phospholipids. PLA2s have an important role in cellular death that occurs via necrosis or apoptosis. Reactive oxygen species are known to contribute to tissue damage during injury and inflammation. However, the species can also be sensed by the cells and trigger intracellular signaling cascades during cell death. This review examines recent evidence on the involvement of reactive oxygen species in lipid signaling during apoptosis and necrosis. Attention is focused on activation of PLA2s and lipoxygenases, which play important roles in mediating AA release and metabolism. The participation of several types of PLA2s in AA mobilization from phospholipids is discussed. The involvement of alternative routes for AA mobilization under oxidative stress is also considered.
Export Options
About this article
Cite this article as:
Higuchi Yoshihiro, The Role of Phospholipase A2 and Lipoxygenases Associated with Arachidonic Acid in Oxidative Stress-Induced Cell Injury, Current Enzyme Inhibition 2007; 3 (4) . https://dx.doi.org/10.2174/157340807782330237
DOI https://dx.doi.org/10.2174/157340807782330237 |
Print ISSN 1573-4080 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6662 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Novel Peptides: An Alternative Approach for the Treatment of Diabetes Mellitus
Current Drug Therapy Targeting Antioxidants to Mitochondria: A Potential New Therapeutic Strategy for Cardiovascular Diseases
Current Pharmaceutical Design Nanowired Drug Delivery to Enhance Neuroprotection in Spinal Cord Injury
CNS & Neurological Disorders - Drug Targets Immune-mediated Cerebellar Ataxias: Practical Guidelines and Therapeutic Challenges
Current Neuropharmacology Traumatic Brain Injury and Blood-Brain Barrier Cross-Talk
CNS & Neurological Disorders - Drug Targets Anti-inflammatory, Antioxidant, Lung and Liver Protective Activity of <i>Galaxaura oblongata</i> as Antagonistic Efficacy against LPS using Hematological Parameters and Immunohistochemistry as Biomarkers
Cardiovascular & Hematological Agents in Medicinal Chemistry Nanotechnology Based Theranostic Approaches in Alzheimer's Disease Management: Current Status and Future Perspective
Current Alzheimer Research Cilostazol: Therapeutic Potential Against Focal Cerebral Ischemic Damage
Current Pharmaceutical Design Therapeutic Potential of Drugs Targeting Pathophysiology of Intracerebral Hemorrhage: From Animal Models to Clinical Applications
Current Pharmaceutical Design Semicarbazide-Sensitive Amine Oxidase/Vascular Adhesion Protein 1: Recent Developments Concerning Substrates and Inhibitors of a Promising Therapeutic Target
Current Medicinal Chemistry Meningococcal Disease and Future Drug Targets
CNS & Neurological Disorders - Drug Targets Inflammatory Caspases: Targets for Novel Therapies
Current Pharmaceutical Design Role of Nuclear Steroid Receptors in Apoptosis
Current Medicinal Chemistry Clinical Profile of Relaxin, a Possible New Drug for Human Use
Current Drug Safety Antiepileptic Drugs in the Neurosurgical Intensive Care
Current Pharmaceutical Design HIV-1 Tat Disrupts CX3CL1-CX3CR1 Axis in Microglia via the NF-κBYY1 Pathway
Current HIV Research The Role of Endothelin System in Cardiovascular Disease and the Potential Therapeutic Perspectives of its Inhibition
Current Topics in Medicinal Chemistry Immunoglobulin Free Light Chains in Immune Responses
Current Immunology Reviews (Discontinued) Targeting Peroxisome Proliferator-Activated Receptor Gamma for Generation of Antidiabetic Drug
Current Diabetes Reviews Patent Selections
Recent Patents on Nanotechnology